Suppr超能文献

1972 - 1997年美国向国家法定传染病监测系统报告水痘情况的评估

Evaluation of varicella reporting to the National Notifiable Disease Surveillance System--United States, 1972-1997.

出版信息

MMWR Morb Mortal Wkly Rep. 1999 Jan 29;48(3):55-8.

PMID:9935144
Abstract

Varicella (chickenpox) is a common, highly infectious, vaccine-preventable disease. Before 1995, an estimated 4 million cases of varicella occurred each year in the United States, approximately 100 patients died, and approximately 10,000 persons were hospitalized because of varicella and related complications. Approximately 95% of cases, 66% of hospitalizations, and 45% of the varicella-related deaths occurred among persons aged <20 years (CDC, unpublished data, 1998). In 1972, varicella became nationally notifiable in the United States; subsequently, 46 states and the District of Columbia (DC) provided weekly reports to CDC's National Notifiable Disease Surveillance System (NNDSS). In 1981, varicella was deleted from the weekly morbidity report, and in 1982, states were encouraged to report varicella to NNDSS annually. In 1995, a live, attenuated varicella vaccine was licensed in the United States for routine use in children. This report describes changes in the annual reported incidence of varicella from 1972 to 1997 and discusses the need for increased surveillance with the availability of a vaccine.

摘要

水痘是一种常见的、传染性很强的、可用疫苗预防的疾病。1995年以前,美国每年估计有400万例水痘病例,约100名患者死亡,约10000人因水痘及相关并发症住院。约95%的病例、66%的住院病例以及45%与水痘相关的死亡病例发生在20岁以下人群中(美国疾病控制与预防中心,未发表数据,1998年)。1972年,水痘在美国成为需全国通报的疾病;随后,46个州和哥伦比亚特区(DC)每周向美国疾病控制与预防中心的国家法定传染病监测系统(NNDSS)报告。1981年,水痘从每周发病报告中删除,1982年,鼓励各州每年向NNDSS报告水痘情况。1995年,一种减毒活水痘疫苗在美国获得许可,用于儿童常规接种。本报告描述了1972年至1997年水痘年度报告发病率的变化,并讨论了随着疫苗的出现加强监测的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验